RA
Rapport Therapeutics, Inc. Common Stock (RAPP)
NASDAQ·Healthcare·Biotechnology
$34.03
-3.87%
Mkt Cap $1.33B
Analyst Ratings
Buy
5
Hold
0
Sell
0
Price Target (7 analysts)
$43.33
Range $40.00 – $47.00
Implied Upside
+27.3%
Consensus $43.33 vs current $34.03